Shulkin B L, Shen S W, Sisson J C, Shapiro B
J Nucl Med. 1987 Mar;28(3):315-8.
Iodine-131 MIBG scintigraphy may be used to determine the presence or absence of metastases to the appendicular skeleton in malignant pheochromocytoma and neuroblastoma. Normal bones show no uptake of [131I]MIBG and the joints are seen as photon-deficient areas surrounded by background muscle activity. Discrete concentrations of radioactivity in bone are often seen in patients with malignant pheochromocytoma and neuroblastoma. Bone marrow involvement in neuroblastoma may be indicated by diffuse uptake of [131I]MIBG or focal accumulation at the metaphyses. Uncommonly, bone involvement may not be displayed by the [131I]MIBG images. Since conventional bone scanning agents may also fail to detect these tumors, skeletal scintigraphy with both [131I]MIBG and [99mTc]MDP is necessary to reliably stage malignant pheochromocytoma and neuroblastoma.
碘-131间碘苄胍闪烁扫描术可用于确定恶性嗜铬细胞瘤和神经母细胞瘤患者是否存在转移至四肢骨骼的情况。正常骨骼不摄取[131I]间碘苄胍,关节表现为被背景肌肉活动包围的光子缺乏区。恶性嗜铬细胞瘤和神经母细胞瘤患者的骨骼中常可见放射性的离散聚集。神经母细胞瘤的骨髓受累可能表现为[131I]间碘苄胍的弥漫性摄取或干骺端的局灶性积聚。罕见的是,[131I]间碘苄胍图像可能无法显示骨骼受累情况。由于传统骨扫描剂也可能无法检测到这些肿瘤,因此同时使用[131I]间碘苄胍和[99mTc]亚甲基二膦酸盐进行骨骼闪烁扫描对于准确分期恶性嗜铬细胞瘤和神经母细胞瘤是必要的。